Chinese JV to move Pfizer deeper into emerging market generics
This article was originally published in Scrip
Executive Summary
Pfizer has taken another step away from its traditional business of selling innovative drugs in developed markets through a memorandum of understanding with China's Zhejiang Hisun Pharmaceuticals to set up a joint venture for branded generics.